381 related articles for article (PubMed ID: 25155751)
21. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
[TBL] [Abstract][Full Text] [Related]
22. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma.
Jiang D; Hu B; Wei L; Xiong Y; Wang G; Ni T; Zong C; Ni R; Lu C
Pathol Res Pract; 2015 Mar; 211(3):240-7. PubMed ID: 25547899
[TBL] [Abstract][Full Text] [Related]
23. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
24. Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma.
Wang D; Zhang S; Chen Y; Hu B; Lu C
Hum Pathol; 2018 Feb; 72():80-90. PubMed ID: 29126834
[TBL] [Abstract][Full Text] [Related]
25. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Zhang X; Xu P; Ni W; Fan H; Xu J; Chen Y; Huang W; Lu S; Liang L; Liu J; Chen B; Shi W
Pathol Res Pract; 2016 Mar; 212(3):162-70. PubMed ID: 26804244
[TBL] [Abstract][Full Text] [Related]
26. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
27. [Elevated expression of CLOCK is associated with poor prognosis in hepatocellular carcinoma].
Li B; Yang X; Li J; Yang Y; Yan Z; Zhang H; Mu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):163-168. PubMed ID: 29673458
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of RASA1 Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma.
Chen YL; Huang WC; Yao HL; Chen PM; Lin PY; Feng FY; Chu PY
Anticancer Res; 2017 Feb; 37(2):781-785. PubMed ID: 28179330
[TBL] [Abstract][Full Text] [Related]
29. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
[TBL] [Abstract][Full Text] [Related]
32. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
33. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
34. High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma.
Li Q; Ma Y; Xu W
Mol Med Rep; 2015 Jun; 11(6):4315-20. PubMed ID: 25634514
[TBL] [Abstract][Full Text] [Related]
35. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
[TBL] [Abstract][Full Text] [Related]
36. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
37. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
40. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
